The capsule of <it>Porphyromonas gingivalis </it>reduces the immune response of human gingival fibroblasts

<p>Abstract</p> <p>Background</p> <p>Periodontitis is a bacterial infection of the periodontal tissues. The Gram-negative anaerobic bacterium <it>Porphyromonas gingivalis </it>is considered a major causative agent. One of the virulence factors of <it>P...

Full description

Bibliographic Details
Main Authors: van Winkelhoff Arie J, Laine Marja L, Deng Dong M, El Idrissi Nawal B, Scheres Nina, Brunner Jorg, Crielaard Wim
Format: Article
Language:English
Published: BMC 2010-01-01
Series:BMC Microbiology
Online Access:http://www.biomedcentral.com/1471-2180/10/5
id doaj-9522453fbb5a4795a0bd4cdf2969d230
record_format Article
spelling doaj-9522453fbb5a4795a0bd4cdf2969d2302020-11-24T21:59:20ZengBMCBMC Microbiology1471-21802010-01-01101510.1186/1471-2180-10-5The capsule of <it>Porphyromonas gingivalis </it>reduces the immune response of human gingival fibroblastsvan Winkelhoff Arie JLaine Marja LDeng Dong MEl Idrissi Nawal BScheres NinaBrunner JorgCrielaard Wim<p>Abstract</p> <p>Background</p> <p>Periodontitis is a bacterial infection of the periodontal tissues. The Gram-negative anaerobic bacterium <it>Porphyromonas gingivalis </it>is considered a major causative agent. One of the virulence factors of <it>P. gingivalis </it>is capsular polysaccharide (CPS). Non-encapsulated strains have been shown to be less virulent in mouse models than encapsulated strains.</p> <p>Results</p> <p>To examine the role of the CPS in host-pathogen interactions we constructed an insertional isogenic <it>P. gingivalis </it>knockout in the epimerase-coding gene <it>epsC </it>that is located at the end of the CPS biosynthesis locus. This mutant was subsequently shown to be non-encapsulated. K1 capsule biosynthesis could be restored by <it>in trans </it>expression of an intact <it>epsC </it>gene. We used the <it>epsC </it>mutant, the W83 wild type strain and the complemented mutant to challenge human gingival fibroblasts to examine the immune response by quantification of <it>IL-1β</it>, <it>IL-6 </it>and <it>IL-8 </it>transcription levels. For each of the cytokines significantly higher expression levels were found when fibroblasts were challenged with the <it>epsC </it>mutant compared to those challenged with the W83 wild type, ranging from two times higher for IL-1β to five times higher for IL-8.</p> <p>Conclusions</p> <p>These experiments provide the first evidence that <it>P. gingivalis </it>CPS acts as an interface between the pathogen and the host that may reduce the host's pro-inflammatory immune response. The higher virulence of encapsulated strains may be caused by this phenomenon which enables the bacteria to evade the immune system.</p> http://www.biomedcentral.com/1471-2180/10/5
collection DOAJ
language English
format Article
sources DOAJ
author van Winkelhoff Arie J
Laine Marja L
Deng Dong M
El Idrissi Nawal B
Scheres Nina
Brunner Jorg
Crielaard Wim
spellingShingle van Winkelhoff Arie J
Laine Marja L
Deng Dong M
El Idrissi Nawal B
Scheres Nina
Brunner Jorg
Crielaard Wim
The capsule of <it>Porphyromonas gingivalis </it>reduces the immune response of human gingival fibroblasts
BMC Microbiology
author_facet van Winkelhoff Arie J
Laine Marja L
Deng Dong M
El Idrissi Nawal B
Scheres Nina
Brunner Jorg
Crielaard Wim
author_sort van Winkelhoff Arie J
title The capsule of <it>Porphyromonas gingivalis </it>reduces the immune response of human gingival fibroblasts
title_short The capsule of <it>Porphyromonas gingivalis </it>reduces the immune response of human gingival fibroblasts
title_full The capsule of <it>Porphyromonas gingivalis </it>reduces the immune response of human gingival fibroblasts
title_fullStr The capsule of <it>Porphyromonas gingivalis </it>reduces the immune response of human gingival fibroblasts
title_full_unstemmed The capsule of <it>Porphyromonas gingivalis </it>reduces the immune response of human gingival fibroblasts
title_sort capsule of <it>porphyromonas gingivalis </it>reduces the immune response of human gingival fibroblasts
publisher BMC
series BMC Microbiology
issn 1471-2180
publishDate 2010-01-01
description <p>Abstract</p> <p>Background</p> <p>Periodontitis is a bacterial infection of the periodontal tissues. The Gram-negative anaerobic bacterium <it>Porphyromonas gingivalis </it>is considered a major causative agent. One of the virulence factors of <it>P. gingivalis </it>is capsular polysaccharide (CPS). Non-encapsulated strains have been shown to be less virulent in mouse models than encapsulated strains.</p> <p>Results</p> <p>To examine the role of the CPS in host-pathogen interactions we constructed an insertional isogenic <it>P. gingivalis </it>knockout in the epimerase-coding gene <it>epsC </it>that is located at the end of the CPS biosynthesis locus. This mutant was subsequently shown to be non-encapsulated. K1 capsule biosynthesis could be restored by <it>in trans </it>expression of an intact <it>epsC </it>gene. We used the <it>epsC </it>mutant, the W83 wild type strain and the complemented mutant to challenge human gingival fibroblasts to examine the immune response by quantification of <it>IL-1β</it>, <it>IL-6 </it>and <it>IL-8 </it>transcription levels. For each of the cytokines significantly higher expression levels were found when fibroblasts were challenged with the <it>epsC </it>mutant compared to those challenged with the W83 wild type, ranging from two times higher for IL-1β to five times higher for IL-8.</p> <p>Conclusions</p> <p>These experiments provide the first evidence that <it>P. gingivalis </it>CPS acts as an interface between the pathogen and the host that may reduce the host's pro-inflammatory immune response. The higher virulence of encapsulated strains may be caused by this phenomenon which enables the bacteria to evade the immune system.</p>
url http://www.biomedcentral.com/1471-2180/10/5
work_keys_str_mv AT vanwinkelhoffariej thecapsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts
AT lainemarjal thecapsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts
AT dengdongm thecapsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts
AT elidrissinawalb thecapsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts
AT scheresnina thecapsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts
AT brunnerjorg thecapsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts
AT crielaardwim thecapsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts
AT vanwinkelhoffariej capsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts
AT lainemarjal capsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts
AT dengdongm capsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts
AT elidrissinawalb capsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts
AT scheresnina capsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts
AT brunnerjorg capsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts
AT crielaardwim capsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts
_version_ 1725847753981952000